...
首页> 外文期刊>Experimental and therapeutic medicine >Inhibitory effect of gene combination in a mouse model of colon cancer with liver metastasis
【24h】

Inhibitory effect of gene combination in a mouse model of colon cancer with liver metastasis

机译:基因组合对结肠癌肝转移小鼠模型的抑制作用

获取原文
获取原文并翻译 | 示例

摘要

The aim of the present study was to establish an animal liver metastasis model with human colon cancer and investigate the inhibitory effect of the wild type (WT) p53 gene combined with thymidine kinase/ganciclovir (TK/GCV) and cytosine deaminase/5-fluorocytosine (CD/5-FC) systems on liver metastasis of colon cancer. A nude mouse liver metastasis model with human colon cancer was established via a spleen cultivation method. A total of 32 nude mice were randomly divided into four groups, each group with eight mice. Group 1 mice received splenic injections of SW480 cells (control group), while group 2 mice were injected with SW480/p53 cells in the spleen. Group 3 mice were administered splenic injections of SW480/TK-CD cells, and GCV and 5-FC were injected into the abdominal cavity. Finally, group 4 mice received splenic injections of SW480/p53 cells mixed in equal proportion with SW480/TK-CD cells, as well as GCV and 5-FC injections in the abdominal cavity. These cells described were constructed in our laboratory and other laboratories. The number of liver metastatic tumors, the liver metastasis rate, conventional pathology, electron microscopy and other indicators in the nude mice of each group were compared and observed. The nude mouse liver metastasis model with human colon cancer was successfully established; the liver metastasis rate of the control group was 100%. The results demonstrated that the rate of liver metastasis in the nude mice in each treatment group decreased, as well as the average number of liver metastatic tumors. Furthermore, the effect of the treatment group with genetic combination (group 4) was the most effective, demonstrating that WTp53 had a synergistic effect with TK/GCV and CD/5-FC. Therefore, the present study successfully established a mouse model of liver metastasis with colon cancer by injecting human colon cancer cells in the spleen. Combined gene therapy was shown to have a synergistic effect, which effectively inhibited the formation of liver metastasis from colon cancer.
机译:本研究的目的是建立具有人类结肠癌的动物肝转移模型,并研究野生型(WT)p53基因与胸苷激酶/更昔洛韦(TK / GCV)和胞嘧啶脱氨酶/ 5-氟胞嘧啶结合的抑制作用(CD / 5-FC)系统对结肠癌的肝转移。通过脾脏培养法建立人结肠癌裸鼠肝转移模型。将总共​​32只裸鼠随机分为四组,每组八只小鼠。第1组小鼠脾脏注射SW480细胞(对照组),而第2组小鼠脾脏注射SW480 / p53细胞。给第3组小鼠脾脏注射SW480 / TK-CD细胞,并将GCV和5-FC注射入腹腔。最后,第4组小鼠脾脏注射了与SW480 / TK-CD细胞等比例混合的SW480 / p53细胞,并在腹腔中注射了GCV和5-FC。所描述的这些单元是在我们的实验室和其他实验室中构建的。比较并观察各组裸鼠的肝转移瘤数目,肝转移率,常规病理学,电子显微镜及其他指标。成功建立人结肠癌裸鼠肝转移模型。对照组肝转移率为100%。结果表明,每个治疗组的裸鼠的肝转移率均降低,并且肝转移肿瘤的平均数量也降低。此外,具有基因组合的治疗组(第4组)的效果最有效,表明WTp53与TK / GCV和CD / 5-FC具有协同作用。因此,本研究通过在脾脏中注射人结肠癌细胞成功建立了结肠癌肝转移小鼠模型。联合基因治疗被证明具有协同作用,可有效抑制结肠癌肝转移的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号